Immune Status and Disease Control of Inflammatory Airway Diseases

Key facts

Sponsor

First Affiliated Hospital of Ningbo University

Enrollment

200 enrolled

Eligibility

18 years · All sexes

Timeline

2025 – 2026

Study locations (1)

• The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Allergic bronchopulmonary aspergillosis

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT07362667
  A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA
  Qianfoshan Hospital
• RECRUITINGNCT07362693
  A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA
  Qianfoshan Hospital
• RECRUITINGNCT07530770
  Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis
  Qianfoshan Hospital
• RECRUITINGNCT07313904
  Effects of Environmental Fungal Exposure on Bronchial Asthma, ABPA and Bronchiectasis
  First Affiliated Hospital of Ningbo University
• RECRUITINGNCT07040332
  Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis
  Qianfoshan Hospital
• RECRUITINGPHASE2NCT06244979
  iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine
  Radboud University Medical Center
• RECRUITINGPHASE3NCT06174922
  A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis
  Post Graduate Institute of Medical Education and Research, Chandigarh
• RECRUITINGNANCT05444946
  Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome
  Post Graduate Institute of Medical Education and Research, Chandigarh

See all trials for Allergic bronchopulmonary aspergillosis →